Halo Labs Introduces 0.8µm Black Membrane Plates for Viscous Drug Product Particle Characterization

BURLINGAME, CA – November 1, 2023 – Halo Labs, a leading life sciences company advancing particle analysis for all drug therapies, launched a new consumables plate providing large molecule drug developers who are looking to count, size, image, and identify particles in highly concentrated and highly viscous solutions. Added to the family of consumables are the new 0.8 µm black membrane plates for Fluorescence Membrane Microscopy (FMM).

Specifically designed for Aura® systems with fluorescence channels, the 0.8 µm black membrane plates provide the same reliable, accurate, and high throughput format customers are accustomed to using but now with larger pores. “Drug developers are pushing the limits of protein and excipient concentrations, to highly viscous solutions,” said Rick Gordon, CEO at Halo Labs. “We’ve heard our customers and with these new plates, our customers can add the capability of identifying and quantitating particles of interest in these complex products.”